Clinical and laboratory characteristics of 144 patients with mediterranean spotted fever.
Antón
E
E
Department of Internal Medicine, Corporació Parc Taulí, Parc Taulí s/n, 08208, Sabadell, Barcelona, Spain. eanton@cspt.es
Font
B
B
Muñoz
T
T
Sanfeliu
I
I
Segura
F
F
D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001774:Blood Chemical Analysis; D001907:Boutonneuse Fever / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology*; D002648:Child; D002675:Child, Preschool; D019411:Clinical Laboratory Techniques; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D015570:Josamycin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012042:Registries; D020114:Rickettsia conorii / Q000187:drug effects / Q000302:isolation & purification*; D012307:Risk Factors; D012698:Serologic Tests / Q000379:methods; D012720:Severity of Illness Index; D017678:Sex Distribution; D013030:Spain / Q000453:epidemiology
D000900:Anti-Bacterial Agents; D015570:Josamycin